CIK 0001531048
NARI Inari Medical, Inc.
Insider trading from SEC Form 4. Last filing Feb 19, 2025.
Last 90 days
Net insider value
$0
no open-market trades
Buys
0
$0 by 0 insiders
Sells
0
$0 by 0 insiders
Insiders on file
12
with a Form 4 at this company
Signals
Open-market buys and sells at Inari Medical, Inc., scored.
| Score | Insider | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 30Weak | William Hoffman director sell | $12M 200,000 shares | -46% | - | |
| 31Weak | Andrew Hykes President and CEO sell | $166k 3,000 shares | -1% | - | |
| 40Moderate | William Hoffman director sell | $3.3M 60,000 shares | -12% | - | |
| 22Weak | Thomas Tu Chief Medical Officer sell | $220k 4,000 shares | -1% | - | |
| 24Weak | Andrew Hykes President and CEO sell | $152k 3,000 shares | -1% | - | |
| 33Weak | William Hoffman director sell | $3.1M 60,000 shares | -11% | - | |
| 28Weak | William Hoffman director sell | $2.0M 40,000 shares | -7% | - | |
| 24Weak | Andrew Hykes President and CEO sell | $150k 3,000 shares | -1% | - | |
| 28Weak | William Hoffman director sell | $1.8M 40,000 shares | -6% | - |
Transactions
The last 83 rows filed, every code.
| Date | Insider | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Feb 19, 2025 | Cynthia L Lucchese director | UTender of shares Common Stock | -38,429 | - | - | 0 | Feb 19, 2025 |
| Feb 19, 2025 | Catherine M. Szyman director | UTender of shares Common Stock | -22,429 | - | - | 0 | Feb 19, 2025 |
| Feb 19, 2025 | Kevin T Strange Chief Financial Officer | UTender of shares Common Stock | -67,502 | - | - | 0 | Feb 19, 2025 |
| Feb 19, 2025 | Karen Silva Principal Accounting Officer | UTender of shares Common Stock | -14,719 | - | - | 0 | Feb 19, 2025 |
| Feb 19, 2025 | Jonathan D Root director | UTender of shares Common Stock | -541,149 | - | - | 0 | Feb 19, 2025 |
| Feb 19, 2025 | Donald B Milder director | UTender of shares Common Stock | -259,126 | - | - | 0 | Feb 19, 2025 |
| Feb 19, 2025 | Dana G Mead Jr. director | UTender of shares Common Stock | -11,148 | - | - | 0 | Feb 19, 2025 |
| Feb 19, 2025 | Thomas Tu Chief Medical Officer | AGrant or award Common Stock | +7,406 | - | - | 478,767 | Feb 19, 2025 |
| Feb 19, 2025 | Robert Keith Warner director | UTender of shares Common Stock | -12,149 | - | - | 0 | Feb 19, 2025 |
| Feb 19, 2025 | Rebecca Chambers director | UTender of shares Common Stock | -9,684 | - | - | 0 | Feb 19, 2025 |
| Feb 19, 2025 | Andrew Hykes President and CEO | UTender of shares Common Stockindirect: By Child 1 | -1,550 | - | - | 0 | Feb 19, 2025 |
| Feb 19, 2025 | William Hoffman director | UTender of shares Common Stock | -238,987 | - | - | 0 | Feb 19, 2025 |
| Feb 19, 2025 | Thomas Tu Chief Medical Officer | UTender of shares Common Stock | -478,767 | - | - | 0 | Feb 19, 2025 |
| Feb 19, 2025 | Catherine M. Szyman director | DDisposition to issuer Stock Optionderivative | -49,719 | - | - | 0 | Feb 19, 2025 |
| Feb 19, 2025 | Cynthia L Lucchese director | DDisposition to issuer Stock Optionderivative | -49,719 | - | - | 0 | Feb 19, 2025 |
| Feb 19, 2025 | Donald B Milder director | UTender of shares Common Stockindirect: Milder Community Property Trust | -2,831,714 | - | - | 0 | Feb 19, 2025 |
| Feb 19, 2025 | Jonathan D Root director | UTender of shares Common Stockindirect: Directly Owned by Spouse | -335 | - | - | 0 | Feb 19, 2025 |
| Feb 19, 2025 | Andrew Hykes President and CEO | UTender of shares Common Stockindirect: By Child 2 | -1,550 | - | - | 0 | Feb 19, 2025 |
| Feb 19, 2025 | Kevin T Strange Chief Financial Officer | DDisposition to issuer Stock Optionderivative | -11,761 | - | - | 0 | Feb 19, 2025 |
| Feb 19, 2025 | Kevin T Strange Chief Financial Officer | DDisposition to issuer Stock Optionderivative | -5,293 | - | - | 0 | Feb 19, 2025 |
| Feb 19, 2025 | Thomas Tu Chief Medical Officer | DDisposition to issuer Stock Optionderivative | -16,599 | - | - | 0 | Feb 19, 2025 |
| Feb 19, 2025 | Andrew Hykes President and CEO | UTender of shares Common Stockindirect: By Child 3 | -1,550 | - | - | 0 | Feb 19, 2025 |
| Feb 19, 2025 | Thomas Tu Chief Medical Officer | DDisposition to issuer Stock Options (Right to Buy)derivative | -16,231 | - | - | 0 | Feb 19, 2025 |
| Feb 19, 2025 | Andrew Hykes President and CEO | UTender of shares Common Stockindirect: By Spouse | -1,000 | - | - | 0 | Feb 19, 2025 |
| Feb 19, 2025 | Andrew Hykes President and CEO | AGrant or award Common Stock | +20,393 | - | - | 717,637 | Feb 19, 2025 |
| Feb 19, 2025 | Andrew Hykes President and CEO | UTender of shares Common Stock | -717,637 | - | - | 0 | Feb 19, 2025 |
| Feb 19, 2025 | Andrew Hykes President and CEO | DDisposition to issuer Stock Options (Right to Buy)derivative | -36,085 | - | - | 0 | Feb 19, 2025 |
| Feb 19, 2025 | Andrew Hykes President and CEO | DDisposition to issuer Stock Options (Right to Buy)derivative | -44,693 | - | - | 0 | Feb 19, 2025 |
| Feb 10, 2025 | Andrew Hykes President and CEO | MOption exercise Common Stock | +161,100 | $0.43 | $69k | 663,806 | Feb 12, 2025 |
| Feb 10, 2025 | Thomas Tu Chief Medical Officer | MOption exercise Common Stock | +139,584 | $0.46 | $64k | 462,941 | Feb 12, 2025 |
| Feb 10, 2025 | Andrew Hykes President and CEO | MOption exercise Common Stock | +16,719 | $6.45 | $108k | 680,525 | Feb 12, 2025 |
| Feb 10, 2025 | Thomas Tu Chief Medical Officer | MOption exercise Common Stock | +8,420 | $6.45 | $54k | 471,361 | Feb 12, 2025 |
| Feb 10, 2025 | Andrew Hykes President and CEO | MOption exercise Common Stock | +16,719 | $0.46 | $7,639 | 697,244 | Feb 12, 2025 |
| Feb 10, 2025 | Thomas Tu Chief Medical Officer | MOption exercise Stock Optionderivative | -139,584 | $0.00 | $0 | 0 | Feb 12, 2025 |
| Feb 10, 2025 | Thomas Tu Chief Medical Officer | MOption exercise Stock Optionderivative | -8,420 | $0.00 | $0 | 0 | Feb 12, 2025 |
| Feb 10, 2025 | Andrew Hykes President and CEO | MOption exercise Stock Options (Right to Buy)derivative | -161,100 | $0.00 | $0 | 0 | Feb 12, 2025 |
| Feb 10, 2025 | Andrew Hykes President and CEO | MOption exercise Stock Optionderivative | -16,719 | $0.00 | $0 | 0 | Feb 12, 2025 |
| Feb 10, 2025 | Andrew Hykes President and CEO | MOption exercise Stock Optionderivative | -16,719 | $0.00 | $0 | 0 | Feb 12, 2025 |
| Feb 4, 2025 | Kevin T Strange Chief Financial Officer | AGrant or award Common Stock | +21,102 | $0.00 | $0 | 67,502 | Feb 6, 2025 |
| Feb 4, 2025 | Thomas Tu Chief Medical Officer | AGrant or award Common Stock | +21,102 | $0.00 | $0 | 323,357 | Feb 6, 2025 |
| Feb 4, 2025 | Andrew Hykes President and CEO | AGrant or award Common Stock | +67,282 | $0.00 | $0 | 502,706 | Feb 6, 2025 |
| Feb 4, 2025 | Karen Silva Principal Accounting Officer | AGrant or award Common Stock | +5,504 | $0.00 | $0 | 14,719 | Feb 6, 2025 |
| Jan 6, 2025 | William Hoffman director | SOpen-market sale Common Stock10b5-1 | -141,075 | $60.13 | $8.5M | 297,912 | Jan 8, 2025 |
| Jan 6, 2025 | William Hoffman director | SOpen-market sale Common Stock10b5-1 | -58,925 | $61.27 | $3.6M | 238,987 | Jan 8, 2025 |
| Jan 1, 2025 | William Hoffman director | FTax withholding Common Stock | -713 | $51.05 | $36k | 440,520 | Jan 3, 2025 |
| Jan 1, 2025 | Andrew Hykes President and CEO | FTax withholding Common Stock | -509 | $51.05 | $26k | 438,801 | Jan 3, 2025 |
| Jan 1, 2025 | Thomas Tu Chief Medical Officer | FTax withholding Common Stock | -337 | $51.05 | $17k | 303,699 | Jan 3, 2025 |
| Jan 1, 2025 | Kevin T Strange Chief Financial Officer | FTax withholding Common Stock | -63 | $51.05 | $3,216 | 47,292 | Jan 3, 2025 |
| Jan 1, 2025 | William Hoffman director | FTax withholding Common Stock | -1,533 | $51.05 | $78k | 438,987 | Jan 3, 2025 |
| Jan 1, 2025 | Andrew Hykes President and CEO | FTax withholding Common Stock | -949 | $51.05 | $48k | 437,852 | Jan 3, 2025 |
| Jan 1, 2025 | Kevin T Strange Chief Financial Officer | FTax withholding Common Stock | -149 | $51.05 | $7,606 | 47,143 | Jan 3, 2025 |
| Jan 1, 2025 | Thomas Tu Chief Medical Officer | FTax withholding Common Stock | -699 | $51.05 | $36k | 303,000 | Jan 3, 2025 |
| Jan 1, 2025 | Thomas Tu Chief Medical Officer | FTax withholding Common Stock | -751 | $51.05 | $38k | 302,249 | Jan 3, 2025 |
| Jan 1, 2025 | Kevin T Strange Chief Financial Officer | FTax withholding Common Stock | -176 | $51.05 | $8,985 | 46,967 | Jan 3, 2025 |
| Jan 1, 2025 | Andrew Hykes President and CEO | FTax withholding Common Stock | -1,632 | $51.05 | $83k | 436,220 | Jan 3, 2025 |
| Jan 1, 2025 | Thomas Tu Chief Medical Officer | FTax withholding Common Stock | -516 | $51.05 | $26k | 301,733 | Jan 3, 2025 |
| Jan 1, 2025 | Andrew Hykes President and CEO | FTax withholding Common Stock | -1,319 | $51.05 | $67k | 434,901 | Jan 3, 2025 |
| Jan 1, 2025 | Kevin T Strange Chief Financial Officer | FTax withholding Common Stock | -227 | $51.05 | $12k | 46,740 | Jan 3, 2025 |
| Jan 1, 2025 | Kevin T Strange Chief Financial Officer | FTax withholding Common Stock | -276 | $51.05 | $14k | 46,464 | Jan 3, 2025 |
| Jan 1, 2025 | Kevin T Strange Chief Financial Officer | FTax withholding Common Stock | -146 | $51.05 | $7,453 | 46,318 | Jan 3, 2025 |
| Dec 20, 2024 | Andrew Hykes President and CEO | SOpen-market sale Common Stock10b5-1 | -2,400 | $55.20 | $132k | 439,910 | Dec 20, 2024 |
| Dec 20, 2024 | Andrew Hykes President and CEO | SOpen-market sale Common Stock10b5-1 | -600 | $55.65 | $33k | 439,310 | Dec 20, 2024 |
| Dec 16, 2024 | William Hoffman director | SOpen-market sale Common Stock10b5-1 | -3,176 | $54.33 | $173k | 498,057 | Dec 18, 2024 |
| Dec 16, 2024 | William Hoffman director | SOpen-market sale Common Stock10b5-1 | -20,917 | $55.23 | $1.2M | 477,140 | Dec 18, 2024 |
| Dec 16, 2024 | William Hoffman director | SOpen-market sale Common Stock10b5-1 | -13,560 | $56.45 | $765k | 463,580 | Dec 18, 2024 |
| Dec 16, 2024 | William Hoffman director | SOpen-market sale Common Stock10b5-1 | -2,347 | $56.82 | $133k | 461,233 | Dec 18, 2024 |
| Dec 16, 2024 | William Hoffman director | SOpen-market sale Common Stock10b5-1 | -2,100 | $54.42 | $114k | 459,133 | Dec 18, 2024 |
| Dec 16, 2024 | William Hoffman director | SOpen-market sale Common Stock10b5-1 | -10,301 | $55.27 | $569k | 448,832 | Dec 18, 2024 |
| Dec 16, 2024 | William Hoffman director | SOpen-market sale Common Stock10b5-1 | -7,467 | $56.51 | $422k | 441,365 | Dec 18, 2024 |
| Dec 16, 2024 | William Hoffman director | SOpen-market sale Common Stock10b5-1 | -132 | $56.89 | $7,509 | 441,233 | Dec 18, 2024 |
| Dec 10, 2024 | Thomas Tu Chief Medical Officer | SOpen-market sale Common Stock10b5-1 | -4,000 | $55.00 | $220k | 304,036 | Dec 12, 2024 |
| Dec 1, 2024 | Karen Silva Principal Accounting Officer | AGrant or award Common Stock | +9,215 | $0.00 | $0 | 9,215 | Dec 3, 2024 |
| Nov 20, 2024 | Andrew Hykes President and CEO | SOpen-market sale Common Stock10b5-1 | -3,000 | $50.83 | $152k | 442,310 | Nov 22, 2024 |
| Nov 18, 2024 | William Hoffman director | SOpen-market sale Common Stock10b5-1 | -3,000 | $50.09 | $150k | 558,233 | Nov 20, 2024 |
| Nov 18, 2024 | William Hoffman director | SOpen-market sale Common Stock10b5-1 | -33,784 | $51.32 | $1.7M | 524,449 | Nov 20, 2024 |
| Nov 18, 2024 | William Hoffman director | SOpen-market sale Common Stock10b5-1 | -3,216 | $52.11 | $168k | 521,233 | Nov 20, 2024 |
| Nov 18, 2024 | William Hoffman director | SOpen-market sale Common Stock10b5-1 | -10,250 | $50.64 | $519k | 510,983 | Nov 20, 2024 |
| Nov 18, 2024 | William Hoffman director | SOpen-market sale Common Stock10b5-1 | -9,750 | $51.16 | $499k | 501,233 | Nov 20, 2024 |
| Oct 29, 2024 | William Hoffman director | SOpen-market sale Common Stock10b5-1 | -20,000 | $50.10 | $1.0M | 581,233 | Oct 31, 2024 |
| Oct 29, 2024 | Andrew Hykes President and CEO | SOpen-market sale Common Stock10b5-1 | -3,000 | $50.00 | $150k | 445,310 | Oct 31, 2024 |
| Oct 29, 2024 | William Hoffman director | SOpen-market sale Common Stock10b5-1 | -20,000 | $50.00 | $1.0M | 561,233 | Oct 31, 2024 |
| Oct 16, 2024 | William Hoffman director | SOpen-market sale Common Stock10b5-1 | -27,804 | $44.78 | $1.2M | 613,429 | Oct 18, 2024 |
| Oct 16, 2024 | William Hoffman director | SOpen-market sale Common Stock10b5-1 | -12,196 | $45.57 | $556k | 601,233 | Oct 18, 2024 |
Insiders
Everyone who has filed a Form 4 here.
- Rebecca Chamberscfo, officer, director
- William Hoffmandirector
- Andrew HykesPresident and CEO
- Cynthia L Lucchesedirector
- Donald B Milderdirector
- Dana G Mead Jr.director
- Jonathan D Rootdirector
- Karen SilvaPrincipal Accounting Officer
- Kevin T StrangeChief Financial Officer
- Catherine M. Szymandirector
- Thomas TuChief Medical Officer
- Robert Keith Warnerdirector
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.